Benchmark Reiterates Speculative Buy on Tenon Medical, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Tenon Medical (NASDAQ:TNON) and maintained a $3 price target.
August 14, 2024 | 2:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Tenon Medical and maintained a $3 price target.
The reiteration of a Speculative Buy rating and the maintenance of a $3 price target by a reputable analyst can positively influence investor sentiment and potentially drive short-term price appreciation for Tenon Medical.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100